NJ State Employees Deferred Compensation Plan - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2019$285,000
-5.6%
8,000
-11.1%
0.05%
-7.3%
Q1 2019$302,000
+2.0%
9,0000.0%0.06%
-11.3%
Q4 2018$296,000
+1.0%
9,000
+50.0%
0.06%
+19.2%
Q2 2018$293,000
-65.5%
6,000
-25.0%
0.05%
-65.6%
Q1 2018$850,000
+77.1%
8,000
-60.0%
0.15%
+73.6%
Q3 2017$480,000
-18.2%
20,000
-33.3%
0.09%
-21.6%
Q2 2017$587,000
-16.6%
30,0000.0%0.11%
-17.2%
Q1 2017$704,000
+91.3%
30,0000.0%0.13%
+83.6%
Q4 2016$368,000
-28.5%
30,0000.0%0.07%
-31.8%
Q3 2016$515,000
+20.6%
30,0000.0%0.11%
+17.6%
Q2 2016$427,000
-7.2%
30,0000.0%0.09%
-7.1%
Q1 2016$460,000
-9.1%
30,0000.0%0.10%
-5.8%
Q4 2015$506,000
+53.8%
30,0000.0%0.10%
+46.5%
Q3 2015$329,000
-12.3%
30,0000.0%0.07%
-2.7%
Q2 2015$375,000
+13.6%
30,0000.0%0.07%
+14.1%
Q1 2015$330,000
-29.0%
30,0000.0%0.06%
-29.7%
Q4 2014$465,000
+28.5%
30,0000.0%0.09%
+23.0%
Q3 2014$362,000
-6.0%
30,0000.0%0.07%
-2.6%
Q2 2014$385,000
+5.8%
30,0000.0%0.08%
+1.3%
Q1 2014$364,00030,0000.08%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2018
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 1,350,000$22,950,0001.87%
MAVERICK CAPITAL LTD 6,655,625$113,146,0001.81%
Camber Capital Management LP 2,500,000$42,500,0001.49%
Bellevue Group AG 3,866,258$65,726,0000.75%
Adero Partners, LLC 51,500$876,0000.75%
Goodman Financial Corp 108,342$1,842,0000.64%
CM Management, LLC 35,000$595,0000.55%
OSTERWEIS CAPITAL MANAGEMENT INC 424,504$7,217,0000.43%
RICE HALL JAMES & ASSOCIATES, LLC 568,379$9,662,0000.34%
Burleson & Company, LLC 107,736$1,832,0000.32%
View complete list of NEKTAR THERAPEUTICS shareholders